Analysen von Michael Leuchten

14.12.22 Novartis Neutral UBS AG
14.12.22 Roche Neutral UBS AG
14.12.22 Sanofi Neutral UBS AG
14.12.22 Merck Buy UBS AG
12.12.22 Sanofi Neutral UBS AG
07.12.22 GSK Sell UBS AG
06.12.22 Novartis Neutral UBS AG
01.12.22 Sanofi Neutral UBS AG
21.11.22 Sanofi Neutral UBS AG
14.11.22 Roche Neutral UBS AG
11.11.22 GSK Sell UBS AG
10.11.22 AstraZeneca Neutral UBS AG
10.11.22 Merck Neutral UBS AG
08.11.22 Bayer Buy UBS AG
02.11.22 GSK Neutral UBS AG
02.11.22 Novo Nordisk Sell UBS AG
28.10.22 Sanofi Neutral UBS AG
27.10.22 Bayer Buy UBS AG
25.10.22 Novartis Neutral UBS AG
24.10.22 Sartorius vz. Buy UBS AG
21.10.22 GSK Neutral UBS AG
19.10.22 Sartorius vz. Buy UBS AG
18.10.22 Roche Neutral UBS AG
17.10.22 Bayer Buy UBS AG
13.10.22 GSK Neutral UBS AG
10.10.22 Shell (ex Royal Dutch Shell) Buy UBS AG
10.10.22 Bayer Buy UBS AG
29.09.22 Roche Neutral UBS AG
26.09.22 Novartis Neutral UBS AG
26.09.22 Sartorius vz. Buy UBS AG
29.08.22 Bayer Buy UBS AG
25.08.22 Novartis Neutral UBS AG
23.08.22 Novo Nordisk Sell UBS AG
17.08.22 Novo Nordisk Sell UBS AG
04.08.22 Merck Neutral UBS AG
04.08.22 Bayer Buy UBS AG
01.08.22 Bayer Buy UBS AG
27.07.22 Sartorius vz. Buy UBS AG
21.07.22 Roche Neutral UBS AG
21.07.22 Sartorius vz. Buy UBS AG
11.07.22 Roche Neutral UBS AG
28.06.22 Novo Nordisk Sell UBS AG
24.06.22 Novo Nordisk Neutral UBS AG
22.06.22 Bayer Buy UBS AG
14.06.22 AstraZeneca Neutral UBS AG
19.05.22 Bayer Buy UBS AG
16.05.22 Sartorius vz. Buy UBS AG
12.05.22 Merck Neutral UBS AG
11.05.22 Bayer Buy UBS AG
11.05.22 Roche Sell UBS AG